Physician profile
Dana E Ankney
NPI 1134318751
$1,379.12
in general payments reported to CMS, 2019-2025
19 companies · $158 in 2025
The $158 reported for 2025 was more than what a typical Hospitalist provider received nationally (typical 2025 total: $85.87).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $344 · 2020: $51.88 · 2021: $274 · 2022: $134 · 2023: $211 · 2024: $206 · 2025: $158.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $575.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $574.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi Pasteur INC. | $260.26 | 2019-2025 | |
| Pfizer INC. | $209.32 | 2019-2024 | |
| Kaleo, INC. | $172.42 | 2019-2024 | Auvi-Q |
| Sanofi-Aventis U.S. LLC | $118.80 | 2024-2025 | |
| Seqirus USA INC | $71.24 | 2023-2024 | Flucelvax, Flucelvax Quadrivalent |
| Ironshore Pharmaceuticals INC. | $69.15 | 2019-2022 | |
| Merck Sharp & Dohme LLC | $66.37 | 2021-2024 | Vaxelis, Gardasil, Gardasil 9 |
| Rhodes Pharmaceuticals L.P. | $62.38 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $60.29 | 2020-2022 | |
| Cranial Technologies, INC | $59.10 | 2021-2024 | Doc Band |
| Vertical Pharmaceuticals, LLC | $46.40 | 2019-2025 | Relexxii |
| Tris Pharma INC | $44.94 | 2021-2024 | Dyanavel Xr |
| Neos Therapeutics, LP | $42.22 | 2019-2021 | |
| Sobi, INC | $25.81 | 2023 | |
| Alk-Abello, INC | $17.72 | 2025 | Neffy |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Corium, LLC | $15.23 | 2021 | |
| Collegium Pharmaceutical, INC. | $13.72 | 2025 | Jornay Pm |
| Arbor Pharmaceuticals, INC. | $12.60 | 2019 | |
| Shire North American Group INC | $11.15 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dana Ankney listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.